Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hepatitis b patients with normal ALT: TMF trial underway

NCT ID NCT05797714

First seen Nov 17, 2025 · Last updated May 24, 2026 · Updated 23 times

Summary

This study tests a drug called TMF (amibufenamide) in 200 adults with chronic hepatitis B who have normal liver enzyme (ALT) levels. The goal is to see if TMF can lower the amount of hepatitis B virus in the blood to undetectable levels after 48 weeks. Participants are randomly assigned to receive TMF or no treatment, and researchers will also check for loss of hepatitis B surface antigen, which indicates better disease control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Beijing You'An Hospital, Capital Medical University

    Beijing, China

  • Fuyang Second People's Hospital

    Fuyang, China

  • Jiangsu Province Hospital

    Nanjin, China

  • LiShui People's Hospital of Zhejiang Province

    Lishui, China

  • People's Hospital of Dongyang City

    Dongyang, China

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

    Shanghai, China

  • Shanghai East Hospital

    Shanghai, China

  • The Fifth People's Hospital of Suzhou

    Suzhou, China

  • The Fifth People's Hospital of Wuxi

    Wuxi, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang Province

    Hangzhou, China

  • The Second Xiangya Hospital, Central South University

    Changsha, Hunan, China

Conditions

Explore the condition pages connected to this study.